| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.06 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.06 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.088 | 0.06 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.06 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.06 |